Prosperity Planning’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,000
Closed -$111K 110
2025
Q2
$111K Hold
16,000
0.03% 106
2025
Q1
$76.6K Hold
16,000
0.02% 104
2024
Q4
$82.4K Hold
16,000
0.03% 103
2024
Q3
$58.1K Hold
16,000
0.02% 104
2024
Q2
$77.6K Hold
16,000
0.03% 102
2024
Q1
$84.8K Hold
16,000
0.03% 94
2023
Q4
$81.4K Hold
16,000
0.03% 93
2023
Q3
$85.4K Hold
16,000
0.04% 87
2023
Q2
$80K Hold
16,000
0.03% 89
2023
Q1
$81.8K Buy
+16,000
New +$104K 0.04% 89
2022
Q4
Sell
-16,000
Closed -$120K 79
2022
Q3
$120K Buy
16,000
+1,000
+7% +$8.17K 0.06% 83
2022
Q2
$139K Hold
15,000
0.07% 75
2022
Q1
$145K Hold
15,000
0.07% 71
2021
Q4
$120K Hold
15,000
0.06% 79
2021
Q3
$140K Hold
15,000
0.08% 76
2021
Q2
$143K Hold
15,000
0.09% 70
2021
Q1
$145K Hold
15,000
0.1% 70
2020
Q4
$89K Buy
+15,000
New +$87.4K 0.08% 70

Other funds holding ICCC

Prosperity Planning's ICCC Position: Q3 2025 in Review

Prosperity Planning sold out of ImmuCell (ICCC) in Q3 2025, closing a stake of 16,000 shares — an estimated $111K sold.

Prosperity Planning first reported a position in ICCC in Q4 2020 and held it in 18 quarters. The position peaked at $145K in Q1 2022. 27 funds tracked by Wall St. Rank hold ICCC as of Q3 2025.

  • Prosperity Planning reported no remaining ImmuCell position as of Q3 2025 after selling out during the quarter.
  • Prosperity Planning sold 16,000 ImmuCell shares in Q3 2025, an estimated $111K.
  • Prosperity Planning first reported a position in ImmuCell in Q4 2020 and held it in 18 quarters.
  • Prosperity Planning's ImmuCell position peaked at $145K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q3 2025.

Based on Prosperity Planning's 13F filing for Q3 2025, filed 9 Oct 2025.